Ypsilanti, MINCT06230185Now EnrollingIRB Ready

TNBC - Triple-Negative Breast Cancer Clinical Trial in Ypsilanti, MI

Access cutting-edge tnbc - triple-negative breast cancer treatment through this clinical trial at a research site in Ypsilanti. Study-provided care at no cost to qualified participants.

Sponsored by Personalis Inc.

Quick Self-Assessment

See if you qualify for this Ypsilanti location

Preparing your pre-screening questions…

Expert Care in Ypsilanti

Access tnbc - triple-negative breast cancer specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related tnbc - triple-negative breast cancer treatment provided free

Apply for This Ypsilanti Location

Check if you qualify for this tnbc - triple-negative breast cancer clinical trial in Ypsilanti, MI

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Ypsilanti

    Convenient for MI residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Ypsilanti site if eligible
  4. 4Begin participation

About This TNBC - Triple-Negative Breast Cancer Study in Ypsilanti

A prospective, multicenter, observational study to evaluate the correlation of Molecular Residual Disease (MRD) detection using circulating tumor DNA guided test to pathological complete response (pCR) after neoadjuvant chemotherapy (NAC) in stage I-III triple negative breast cancer (TNBC). Results from this study aim to improve MRD detection and disease outcomes for future patients.

Sponsor: Personalis Inc.

Who Can Participate

Inclusion Criteria

Have histologically documented TNBC (defined as ER expression ≤10% by IHC, PR expression≤10% by IHC and HER2 0 or 1+ by IHC or FISH ratio \<2 or HER2 gene copy number of \<6).
Early-stage breast cancer (stage I-III) and scheduled to undergo NAC treatment with curative intent.
Be informed of the investigational nature of the study and all pertinent aspects of the trial.
Have the ability to understand and the willingness to sign a written informed consent document in accordance with institutional and federal guidelines.
Be ≥ 18years of age.
Patient who are scheduled to start NAC.
Be willing to provide blood samples before and during treatment.
Have available biopsy tissue.

Exclusion Criteria

Receiving concurrent anti-neoplastic therapy for another malignancy.
Stage IV disease.
Current or history of another primary cancer within 5 years of study entry, with the exception of basal or squamous cell skin cancer, or non-invasive malignancy.
History of allogeneic bone marrow or organ transplant.
Blood transfusion within two weeks before collection of blood for central ctDNA testing.
Started systemic therapy for their breast cancer.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Ypsilanti?

Yes, this clinical trial (NCT06230185) has an active research site in Ypsilanti, MI that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

TNBC - Triple-Negative Breast Cancer Treatment Options in Ypsilanti, MI

If you're searching for tnbc - triple-negative breast cancer treatment options in Ypsilanti, MI, this clinical trial (NCT06230185) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Ypsilanti research site is actively enrolling participants for this clinical trial. You'll receive care from experienced tnbc - triple-negative breast cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all tnbc - triple-negative breast cancer clinical trials near you to find additional studies recruiting in your area.

More Breast Cancer Trials in Ypsilanti, MI

See all breast cancer clinical trials recruiting in Ypsilanti — not just this study.

Browse Breast Cancer Trials in Ypsilanti →

Browse More Trials by Condition

Breast Cancer TrialsTriple Negative Breast Cancer TrialsAnkylosing Spondylitis TrialsGeographic Atrophy TrialsAll Conditions →

Ready to Join in Ypsilanti?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Ypsilanti, MI